Spring 2022 After lonely labwork and distancing during the pandemic winter, we are looking forward to spring and freely shared and fun immunology. From left: Taissa, Hanne, Elias, and Kjell-Rune.
Kick-Off Fall 2019 We are saving the world one Escape room at the time. Here, we prevented a massive bioterror attack to be launched from Oslo in just 47 minutes.
Wolf AS, Bjørlykke KH, Ørbo HS, Bhandari S, Solum G, Kjønstad IF, Jyssum I, Nygaard UC, Kristoffersen AB, Christensen IE, Josefsson SE, Lund KP, Chopra A, Osen JR, Chaban V, Tveter AT, Sexton J, Kvien TK, Jahnsen J, Haavardsholm EA, Grødeland G, Vaage JT, Provan SA, Kared H, Lund-Johansen F et al. (2024) T cell responses to repeated SARS-CoV-2 vaccination and breakthrough infections in patients on TNF inhibitor treatment: a prospective cohort study EBioMedicine, 108, 105317 (in press) DOI 10.1016/j.ebiom.2024.105317, PubMed 39260039 Ørbo HS, Bjørlykke KH, Sexton J, Jyssum I, Tveter AT, Christensen IE, Mjaaland S, Kvien TK, Grødeland G, Kro GB, Jahnsen J, Haavardsholm EA, Munthe LA, Provan SA, Vaage JT, Goll GL, Jørgensen KK, Syversen SW (2024) Incidence and outcome of COVID-19 following vaccine and hybrid immunity in patients on immunosuppressive therapy: identification of protective post-immunisation anti-RBD antibody levels in a prospective cohort study RMD Open, 10 (2) DOI 10.1136/rmdopen-2023-003545, PubMed 38599653 Hinke DM, Anderson AM, Katta K, Laursen MF, Tesfaye DY, Werninghaus IC, Angeletti D, Grødeland G, Bogen B, Braathen R (2024) Applying valency-based immuno-selection to generate broadly cross-reactive antibodies against influenza hemagglutinins Nat Commun, 15 (1), 850 DOI 10.1038/s41467-024-44889-w, PubMed 38346952